Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Bethesda North Marriott Hotel and Conference Center

Oct 01, 2015 7:30 AM - Oct 02, 2015 2:45 PM

5701 Marinelli Road, , North Bethesda, MD 20852 , USA

Imaging in Oncology Clinical Trials: Central Audit Methods for Site Interpretation

Participate in cross-functional discussions about current audit method options and discuss how to implement audit plans for site image.

Session 7: Summary - Cost-Benefit Analysis

Session Chair(s)

Session Chair  Invited, BSN, DDS

Session Chair Invited, BSN, DDS

Manager, DIA, Switzerland

This closing session will be a culmination of the two day discussion on central audit methods for site image interpretation in clinical trials. A panel, comprising of the Sessions Chairs, will present the outcomes from the discussions held within their sessions, provide a framework for the central audit method recommendation, and close with a final discussion on the importance of evaluating the many factors involved in making the decision to implement central audit method practices.

Speaker(s)

Annette  Schmid, PhD

Annette Schmid, PhD

Senior Director Scientific & Medical Services, Head of Oncology Imaging Strategy, PAREXEL International, United States

Panelists

David I. Raunig

David I. Raunig

Senior Vice President, Medical & Scientific Affairs, ICON, United States

Susanta  Sarkar

Susanta Sarkar

President, Cadenzamed LLC, United States

Andrea  Perrone, MD

Andrea Perrone, MD

Head of Clinical Imaging, Translational Medicine, Merck, United States

Steven  Sun, PhD

Steven Sun, PhD

Director, Janssen R&D, United States

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.